Where's it on?
FDA · Drugs ·

Tyenne (tocilizumab-aazg) Injection recall

Fresenius Kabi USA, LLC recalled Tyenne (tocilizumab-aazg) Injection on September 2, 2026 because of presence of particulate matter:An internal investigation at the firm found the product to contain glass particles. It was sold nationwide.

Why it was recalled

Presence of particulate matter:An internal investigation at the firm found the product to contain glass particles.

What's recalled

Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Only, Manufactured by Fresenius Kabi USA, LLC, Lake Zurich, Illinois, 60047, NDC 65219-594-20.

Quantity: 4,643 20mL-vials

What to do

Check whether you have the product (match the lot numbers, dates or codes in the official notice). Stop using it, and return it or throw it away as the notice says.

Read the official FDA notice